Bronchoscope Market By Product Type (Flexible Bronchoscopes, Rigid Bronchoscopes); By Usability (Reusable Bronchoscopes, Disposable / Single-use Bronchoscopes); By Visualization (Video Bronchoscopes, Non-Video Bronchoscopes); By Application (Diagnostic Bronchoscopy, Therapeutic Bronchoscopy); By End User (Hospitals & Ambulatory Surgery Centers (ASCs), Specialty Clinics / Outpatient Centers); By Region – Growth, Share, Opportunities & Competitive Analysis, 2025 – 2032
The global Bronchoscope Market size was estimated at USD 945.39 million in 2025 and is expected to reach USD 1,478.81 million by 2032, growing at a CAGR of 6.6% from 2025 to 2032. Demand is primarily supported by the expanding use of bronchoscopy in pulmonary diagnostics and therapeutic interventions, where clinicians increasingly rely on bronchoscopy to improve airway access, tissue sampling, and procedure efficiency. Adoption is further reinforced by hospital upgrades to advanced endoscopy suites and broader availability of bronchoscopy services across large care networks.
REPORT ATTRIBUTE
DETAILS
Historical Period
2020-2024
Base Year
2025
Forecast Period
2026-2032
Bronchoscope Market Size 2025
USD 945.39 million
Bronchoscope Market, CAGR
6.6%
Bronchoscope Market Size 2032
USD 1,478.81 million
Key Market Trends & Insights
Flexible bronchoscopes accounted for the largest share of 61.90% in 2025, supported by broad use across both diagnostic and therapeutic workflows.
Reusable bronchoscopes held 66.10% share in 2025, reflecting the large installed base and established reprocessing pathways in high-volume facilities.
Hospitals & ambulatory surgery centers (ASCs) represented 72.60% share in 2025, driven by higher procedure volumes and complex case mix managed in institutional settings.
Disposable / single-use bronchoscopes are projected to expand at 15.85% CAGR during 2026–2031, reflecting infection-control priorities and simplified logistics for sites lacking reprocessing capacity.
Asia Pacific is projected to grow at 9.51% CAGR during 2026–2031, underpinned by expanding pulmonary care capacity and rising diagnostic procedure volumes.
Segment Analysis
Purchasing decisions in the bronchoscope market are increasingly shaped by workflow efficiency, infection-control protocols, and imaging performance expectations across endoscopy suites. Providers with high bronchoscopy throughput typically prioritize reliability, serviceability, and total cost of ownership, which supports continued investment in reusable fleets, while also expanding access to single-use options for specific use cases and settings. Clinical teams also value consistent visualization quality and ergonomic handling, particularly as bronchoscopy is integrated into more structured diagnostic pathways for pulmonary disease management.
Technology evolution is reinforcing the role of advanced bronchoscopy capabilities in enabling precise targeting and improved procedural confidence. In many facilities, bronchoscopy is being positioned not only as a diagnostic step, but also as a platform for interventional procedures that can reduce invasiveness compared with alternative surgical approaches. As a result, procurement is increasingly tied to system-level considerations such as interoperability with existing tower systems, accessories compatibility, clinician training requirements, and the ability to standardize protocols across multi-site networks.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
Flexible Bronchoscopes accounted for the largest share of 61.90% in 2025. Flexible platforms lead because they support a wider range of clinical indications and can access more distal airway anatomy compared with rigid alternatives. Ongoing improvements in maneuverability, working-channel utility, and visualization performance continue to align with clinician preferences in routine bronchoscopy. Broader procedure volumes in pulmonary diagnostics also reinforce demand for flexible systems across high-throughput settings.
By Usability Insights
Reusable Bronchoscopes accounted for the largest share of 66.10% in 2025. Reusable fleets remain dominant due to established procurement patterns, amortization economics, and standardized reprocessing workflows in large hospitals. Clinical teams often prefer reusable options for consistency, accessory compatibility, and long-term utilization across multiple procedure types. At the same time, infection-control scrutiny and operational simplification are supporting faster adoption of single-use devices, particularly in settings with limited sterilization capacity.
By Visualization Insights
Video bronchoscopes lead qualitative adoption dynamics because they support improved visualization, documentation, and team-based workflows compared with non-video alternatives. Higher expectations for image clarity in diagnostic bronchoscopy, training, and quality assurance encourage providers to modernize visualization capabilities over time. Integration with digital platforms and procedure recording also strengthens the value proposition for video systems in institutional settings. Non-video systems retain relevance mainly in cost-sensitive environments or where infrastructure limitations constrain adoption of advanced visualization platforms.
By Application Insights
Diagnostic bronchoscopy leads qualitative utilization because bronchoscopy remains a standard tool for airway visualization, pulmonary assessment, and sampling pathways used in routine evaluation. Growth in diagnostic demand is reinforced by expanding pulmonary disease burden and broader use of structured work-up pathways that incorporate bronchoscopy. Therapeutic bronchoscopy demand is increasing as minimally invasive interventions become more standardized in hospitals that invest in advanced bronchoscopy suites. Across both applications, procedure volume expansion supports recurring demand for bronchoscopes and compatible accessories.
By End User Insights
Hospitals & ambulatory surgery centers (ASCs) accounted for the largest share of 72.60% in 2025. Hospitals lead due to their ability to manage complex cases, maintain specialized staff, and support advanced bronchoscopy infrastructure for both diagnostics and interventions. ASCs are gaining momentum as payers and providers look to optimize site-of-care economics and improve scheduling throughput for appropriate cases. Specialty clinics and outpatient centers expand where bronchoscopy is increasingly standardized and supported by simplified device workflows and referral network growth.
Bronchoscope Market Drivers
Rising Pulmonary Diagnostic Procedure Volumes
Bronchoscopy demand increases as pulmonary diagnostic pathways expand across major care settings, particularly for evaluation and sampling in complex respiratory cases. Hospitals are investing in bronchoscopy suite capacity to improve procedural throughput and reduce delays in diagnostic work-up. Clinicians also rely on bronchoscopy to support structured decision-making when imaging alone is insufficient. As diagnostic protocols become more standardized, procedure growth translates into recurring replacement and fleet expansion needs. This dynamic supports stable baseline demand across both mature and emerging healthcare markets.
For instance, in a large cohort of 14,228 patients undergoing bronchoscopy, more than 12,000 procedures were performed with reusable flexible bronchoscopes to obtain endobronchial or transbronchial samples that directly informed downstream management decisions.
Technology Upgrades Improving Visualization and Workflow
Ongoing improvements in imaging, ergonomics, and system compatibility strengthen the clinical and operational value of modern bronchoscopes. Providers increasingly prefer platforms that support consistent visualization, simplified handling, and smoother integration with existing endoscopy infrastructure. Workflow efficiency is becoming a core procurement criterion as facilities seek faster turnaround, improved documentation, and standardized training across multi-site networks. These upgrades also encourage replacement of older platforms that no longer meet performance expectations. Technology-led differentiation remains an important lever for manufacturers competing for institutional contracts.
For instance, the EVIS X1 CV‑1500 system with BF‑H1200 (4.9 mm, 2.2 mm channel) and BF‑1TH1200 (5.8 mm, 3.0 mm channel) bronchoscopes combines high-definition optics with advanced image enhancement modes such as TXI, RDI, and BAI‑MAC to improve lesion visibility and navigation through peripheral bronchi.
Infection-Control Focus and Reprocessing Burden
Healthcare systems are prioritizing infection prevention and operational consistency across endoscopy workflows, which influences bronchoscope purchasing decisions. Reprocessing complexity, turnaround time, and compliance requirements place pressure on facilities to optimize sterilization and reduce variability. As a result, many providers adopt mixed fleets that combine reusable and single-use options based on setting and case requirements. This approach supports both continued reusable demand and faster uptake of disposable bronchoscopes in targeted environments. Infection-control priorities remain a strong structural driver, especially in high-volume and resource-constrained settings.
Expansion of Interventional and Therapeutic Bronchoscopy
Therapeutic bronchoscopy demand rises as hospitals expand minimally invasive interventions that can improve patient experience and reduce reliance on more invasive alternatives. Facilities that upgrade bronchoscopy suites are better positioned to perform interventions with improved procedural confidence and operational predictability. Growth is also supported by clinician training expansion and greater availability of specialized pulmonary care teams. As therapeutic use becomes more standardized, device utilization per facility can increase through higher case throughput and broader indication coverage. This driver supports sustained investment in platforms that enable both diagnostic and therapeutic workflows.
Bronchoscope Market Challenges
Cost management remains a key challenge because bronchoscopy purchasing decisions must align with capital budgets, service costs, and total cost of ownership targets. Facilities must balance performance expectations with affordability, particularly when upgrades require ecosystem spending across towers, accessories, and maintenance. Reimbursement variability and differing procurement rules across markets can further slow adoption of higher-cost platforms. In many settings, budget constraints drive extended replacement cycles, creating pressure on manufacturers to justify premium pricing. These factors can temper near-term upgrades despite clear clinical benefits.
Operational variability in reprocessing quality and workflow standardization is another constraint for reusable fleets. Facilities face staffing requirements, compliance documentation burdens, and process variability that can increase downtime and cost per procedure. In parallel, single-use adoption introduces its own operational considerations related to inventory management, supply continuity, and waste handling requirements. Providers often require strong evidence of workflow benefit and infection-control value before switching protocols. This creates a complex purchasing environment where adoption can be gradual and highly setting-dependent.
For instance, an analysis of 14,228 bronchoscopy procedures reported that use of sterile single-use bronchoscopes (Ambu aScope) reduced 30‑day readmission rates from 7.7% with reusable scopes to 3.6%, with patients undergoing procedures with reusable bronchoscopes being 2.3 times more likely to be readmitted, which strengthens the operational and infection‑control case for protocol change in appropriate settings.
Bronchoscope Market Trends and Opportunities
A growing trend is the expansion of hybrid fleet strategies where providers deploy reusable systems for core workloads and single-use bronchoscopes for specific settings or risk profiles. This approach supports standardization across care networks while allowing flexibility in infection-control management and case logistics. Facilities with limited reprocessing capacity, including certain outpatient and ambulatory sites, increasingly adopt single-use devices to streamline turnaround time and staffing needs. Hybrid models also enable procurement teams to optimize cost allocation across departments and procedure types. This trend creates opportunities for manufacturers with broad portfolios and strong clinical support programs.
For instance, Ambu’s aScope 5 Broncho single-use platform, which offers four scope sizes on a common video processing unit, has been used to complete 95% of advanced bronchoscopy procedures in a clinical series without conversion to reusable scopes, while eliminating the 76 minutes of average hands-on reprocessing time per endoscope reported for conventional flexible endoscopes in Olympus reprocessing studies.
Another opportunity area is the increasing preference for digital integration, documentation, and training enablement within bronchoscopy suites. Providers value systems that support consistent visualization quality, recording, and easier team-based learning to reduce procedural variability. As multi-site healthcare networks expand, standardized bronchoscopy protocols and interoperable equipment become more important for quality and productivity. Manufacturers that offer service models, training pathways, and accessories ecosystems aligned to standardized workflows can gain share in institutional tenders. This environment also encourages product innovation focused on usability, durability, and workflow simplification.
Regional Insights
North America
North America held 41.57% share in 2025, supported by strong procedural capacity and broad availability of advanced bronchoscopy infrastructure. Hospitals and large care networks drive purchasing through structured procurement programs and standardization initiatives. Demand is reinforced by the routine use of bronchoscopy across diagnostic and interventional pathways in pulmonary care. Infection-control priorities and workflow optimization also encourage mixed adoption of reusable and single-use devices. Continued technology upgrades remain a key factor shaping replacement and expansion decisions.
Europe
Europe accounted for 24.35% share in 2025, underpinned by mature hospital infrastructure and established endoscopy practices across major healthcare systems. Procurement is often driven by system-wide standardization goals, service requirements, and lifecycle cost considerations. Demand remains stable across diagnostic bronchoscopy, with growth supported by increasing procedural efficiency initiatives within hospitals. Adoption patterns vary across countries depending on reimbursement structures and capital investment cycles. Providers increasingly prioritize equipment reliability, training enablement, and interoperability with existing endoscopy platforms.
Asia Pacific
Asia Pacific represented 21.28% share in 2025 and is supported by expanding healthcare capacity and rising pulmonary procedure volumes. Hospital investment in respiratory diagnostics and minimally invasive care pathways contributes to growing bronchoscopy utilization. Adoption is influenced by uneven infrastructure maturity, with advanced uptake in large urban hospitals and more gradual penetration in secondary facilities. Cost sensitivity drives careful technology selection, but demand benefits from broader access expansion and clinical modernization initiatives. The region’s growth momentum supports continued investment in both reusable and simplified workflow solutions.
Latin America
Latin America reached 7.10% share in 2025, reflecting moderate adoption of bronchoscopy across key hospital hubs and specialist centers. Demand is concentrated in higher-capacity facilities where pulmonary diagnostics and interventional services are available. Budget constraints and procurement variability can extend equipment replacement cycles and limit rapid upgrades. Single-use adoption can be selective, often focused on operational simplicity in facilities with limited reprocessing infrastructure. Over time, expanding diagnostic access and hospital modernization can support steady demand growth.
Middle East & Africa
Middle East & Africa accounted for 5.70% share in 2025, supported by demand concentrated in tertiary hospitals and better-resourced care hubs. Adoption trends vary widely across markets, with advanced bronchoscopy services more prevalent in select countries and urban centers. Procurement decisions often emphasize durability, service support, and standardized training due to staffing and operational constraints. Growth is supported by increasing investment in hospital infrastructure and respiratory care capacity. Wider penetration depends on continued expansion of specialist services beyond major centers.
Competitive Landscape
Competition in the bronchoscope market is shaped by portfolio breadth across reusable and single-use devices, technology differentiation in visualization and usability, and the ability to support large institutional procurement requirements. Suppliers compete on total cost of ownership, service coverage, training enablement, and ecosystem compatibility with existing endoscopy infrastructure. Product performance and workflow efficiency remain central differentiators as facilities prioritize throughput, standardized protocols, and infection-control compliance. Strategic positioning increasingly depends on the ability to address both high-volume hospital requirements and emerging outpatient and ambulatory demand pockets.
Olympus Corporation remains a leading participant with a strong focus on endoscopy ecosystem integration, clinician training support, and continuous upgrades to imaging and handling performance. The company’s approach typically emphasizes compatibility with platform systems used across broader endoscopy suites, enabling standardized workflows for purchasing organizations. Product portfolio depth supports large-scale tenders and long-term replacement cycles, supported by service and clinical education programs. This positioning is reinforced by sustained investment in product refreshes aligned to institutional needs for performance consistency and operational reliability.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
In January 2026, FUJIFILM Healthcare Europe announced the European launch of its EB-710US balloonless ultrasonic bronchoscope, a new flexible ultrasound bronchoscope designed to enhance lung cancer detection and staging with improved workflow and imaging performance.
In February 2026, Olympus Corporation of the Americas reported that the U.S. FDA had cleared pediatric use indications for two H-SteriScope single-use video flexible bronchoscopes in its respiratory portfolio, expanding their application to younger patient populations.
In September 2025, Olympus Corporation introduced its latest endobronchial ultrasound bronchoscope, the BF-UCP190F, in EMEA and major Asia-Pacific markets, highlighting a thinner outer diameter and stronger upward angulation to extend diagnostic reach, with a launch in Japan planned for the following months.
In March 2025, Johnson & Johnson MedTech (Auris Health, MONARCH Platform) announced regulatory clearance for MONARCH Quest, a next-generation advancement of its robotically assisted bronchoscopy platform intended to provide enhanced minimally invasive access and visualization of the airways for peripheral lung procedures.
Report Scope
Report Attribute
Details
Market size value in 2025
USD 945.39 million
Revenue forecast in 2032
USD 1,478.81 million
Growth rate (CAGR)
6.6% (2025–2032)
Base year
2025
Forecast period
2026-2032
Quantitative units
USD million
Segments covered
By Product Type Outlook: Flexible Bronchoscopes, Rigid Bronchoscopes; By Usability Outlook: Reusable Bronchoscopes, Disposable / Single-use Bronchoscopes; By Visualization Outlook: Video Bronchoscopes, Non-Video Bronchoscopes; By Application Outlook: Diagnostic bronchoscopy, Therapeutic bronchoscopy; By End User Outlook: Hospitals & ambulatory surgery centers (ASCs), Specialty clinics / outpatient centers
Regional scope
North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Key companies profiled
Olympus Corporation; Fujifilm Holdings Corporation; Ambu A/S; Medtronic plc; Karl Storz SE & Co. KG; Boston Scientific Corporation; Teleflex Incorporated; Richard Wolf GmbH; Smiths Medical; CONMED Corporation
No.of Pages
327
Segmentation
By Product Type
Flexible Bronchoscopes
Rigid Bronchoscopes
By Usability
Reusable Bronchoscopes
Disposable / Single-use Bronchoscopes
By Visualization
Video Bronchoscopes
Non-Video Bronchoscopes
By Application
Diagnostic bronchoscopy
Therapeutic bronchoscopy
By End User
Hospitals & ambulatory surgery centers (ASCs)
Specialty clinics / outpatient centers
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
South-east Asia
Rest of Asia Pacific
Latin America
Brazil
Argentina
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of the Middle East and Africa
1. Introduction
1.1. Report Description
1.2. Purpose of the Report
1.3. USP & Key Offerings
1.4. Key Benefits for Stakeholders
1.5. Target Audience
1.6. Report Scope
1.7. Regional Scope 2. Scope and Methodology
2.1. Objectives of the Study
2.2. Stakeholders
2.3. Data Sources
2.3.1. Primary Sources
2.3.2. Secondary Sources
2.4. Market Estimation
2.4.1. Bottom-Up Approach
2.4.2. Top-Down Approach
2.5. Forecasting Methodology 3. Executive Summary 4. Introduction
4.1. Overview
4.2. Key Industry Trends 5. Global Bronchoscope Market
5.1. Market Overview
5.2. Market Performance
5.3. Impact of COVID-19
5.4. Market Forecast 6. Market Breakup by Product Type
6.1. Flexible Bronchoscopes
6.1.1. Market Trends
6.1.2. Market Forecast
6.1.3. Revenue Share
6.1.4. Revenue Growth Opportunity
6.2. Rigid Bronchoscopes
6.2.1. Market Trends
6.2.2. Market Forecast
6.2.3. Revenue Share
6.2.4. Revenue Growth Opportunity 7. Market Breakup by Usability
7.1. Reusable Bronchoscopes
7.1.1. Market Trends
7.1.2. Market Forecast
7.1.3. Revenue Share
7.1.4. Revenue Growth Opportunity
7.2. Disposable / Single-use Bronchoscopes
7.2.1. Market Trends
7.2.2. Market Forecast
7.2.3. Revenue Share
7.2.4. Revenue Growth Opportunity 8. Market Breakup by Visualization
8.1. Video Bronchoscopes
8.1.1. Market Trends
8.1.2. Market Forecast
8.1.3. Revenue Share
8.1.4. Revenue Growth Opportunity
8.2. Non-Video Bronchoscopes
8.2.1. Market Trends
8.2.2. Market Forecast
8.2.3. Revenue Share
8.2.4. Revenue Growth Opportunity 9. Market Breakup by Application
9.1. Diagnostic bronchoscopy
9.1.1. Market Trends
9.1.2. Market Forecast
9.1.3. Revenue Share
9.1.4. Revenue Growth Opportunity
9.2. Therapeutic bronchoscopy
9.2.1. Market Trends
9.2.2. Market Forecast
9.2.3. Revenue Share
9.2.4. Revenue Growth Opportunity 10. Market Breakup by End User
10.1. Hospitals & ambulatory surgery centers (ASCs)
10.1.1. Market Trends
10.1.2. Market Forecast
10.1.3. Revenue Share
10.1.4. Revenue Growth Opportunity
10.2. Specialty clinics / outpatient centers
10.2.1. Market Trends
10.2.2. Market Forecast
10.2.3. Revenue Share
10.2.4. Revenue Growth Opportunity 11. Market Breakup by Region
11.1. North America
11.1.1. United States
11.1.1.1. Market Trends
11.1.1.2. Market Forecast
11.1.2. Canada
11.1.2.1. Market Trends
11.1.2.2. Market Forecast
11.1.3. Mexico
11.1.3.1. Market Trends
11.1.3.2. Market Forecast
11.2. Europe
11.2.1. Germany
11.2.2. France
11.2.3. United Kingdom
11.2.4. Italy
11.2.5. Spain
11.2.6. Rest of Europe
11.3. Asia-Pacific
11.3.1. China
11.3.2. Japan
11.3.3. India
11.3.4. South Korea
11.3.5. Australia
11.3.6. Rest of Asia-Pacific
11.4. Latin America
11.4.1. Brazil
11.4.2. Argentina
11.4.3. Rest of Latin America
11.5. Middle East and Africa
11.5.1. GCC Countries
11.5.2. South Africa
11.5.3. Rest of Middle East & Africa 12. SWOT Analysis
12.1. Overview
12.2. Strengths
12.3. Weaknesses
12.4. Opportunities
12.5. Threats 13. Value Chain Analysis 14. Porters Five Forces Analysis
14.1. Overview
14.2. Bargaining Power of Buyers
14.3. Bargaining Power of Suppliers
14.4. Degree of Competition
14.5. Threat of New Entrants
14.6. Threat of Substitutes 15. Price Analysis 16. Competitive Landscape
16.1. Market Structure
16.2. Key Players
16.3. Profiles of Key Players
16.3.1. Olympus Corporation
16.3.1.1. Company Overview
16.3.1.2. Product Portfolio
16.3.1.3. Financials
16.3.1.4. SWOT Analysis
16.3.2. Fujifilm Holdings Corporation
16.3.3. Ambu A/S
16.3.4. Medtronic plc
16.3.5. Karl Storz SE & Co. KG
16.3.6. Boston Scientific Corporation
16.3.7. Teleflex Incorporated
16.3.8. Richard Wolf GmbH
16.3.9. Smiths Medical
16.3.10. CONMED Corporation 17. Research Methodology
Request A Free Sample
We prioritize the confidentiality and security of your data. Our promise: your information remains private.
Ready to Transform Data into Decisions?
Request Your Sample Report and Start Your Journey of Informed Choices
Providing the strategic compass for industry titans.
Frequently Asked Questions:
What is the market size of the Bronchoscope Market in 2025?
The Bronchoscope Market was valued at USD 945.39 million in 2025. Market growth is supported by expanding bronchoscopy use in diagnostic and therapeutic pulmonary care.
What will be the market size of the Bronchoscope Market by 2032?
The Bronchoscope Market is expected to reach USD 1,478.81 million by 2032. Growth is linked to technology upgrades and broader access to bronchoscopy services across care settings.
What is the CAGR for the Bronchoscope Market during 2025–2032?
The Bronchoscope Market is projected to grow at a CAGR of 6.6% from 2025 to 2032. Demand benefits from procedure volume growth and operational emphasis on workflow efficiency.
Which is the largest segment in the Bronchoscope Market?
Flexible bronchoscopes accounted for the largest share of 61.90% in 2025. The segment leads due to broad clinical applicability and suitability across routine bronchoscopy workflows.
What are the key growth factors shaping the Bronchoscope Market?
Growth is supported by rising pulmonary diagnostic volumes, imaging and usability upgrades, and infection-control priorities that influence device selection. Expansion of therapeutic bronchoscopy also supports higher utilization in advanced centers.
Which region leads the Bronchoscope Market?
North America led the Bronchoscope Market with a 41.57% share in 2025. The region benefits from strong hospital infrastructure and broader adoption of advanced bronchoscopy platforms.
About Author
Shweta Bisht
Healthcare & Biotech Analyst
Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.
The global Blood Transfusion Device Market size was estimated at USD 5,283.74 million in 2025 and is expected to reach USD 7,757.84 million by 2032, growing at a CAGR of 5.64% from 2025 to 2032.
The global Brain Monitoring Market size was estimated at USD 7,112.2 million in 2025 and is expected to reach USD 10,694.12 million by 2032, growing at a CAGR of 6% from 2025 to 2032.
The global Bioimpedance Analyzers Market size was estimated at USD 880.14 million in 2025 and is expected to reach USD 2,282 million by 2032, growing at a CAGR of 14.58% from 2025 to 2032.
The global Bioactive Wound Dressing Market size was estimated at USD 5162.78 million in 2025 and is expected to reach USD 10254.45 million by 2032, growing at a CAGR of 10.3% from 2025 to 2032.
The global Autotransfusion Systems Market size was estimated at USD 528.39 million in 2025 and is expected to reach USD 796.6 million by 2032, growing at a CAGR of 6.04% from 2025 to 2032.
The Acoustic Neuroma Market is projected to grow from USD 4,634.09 million in 2025 to an estimated USD 7,638.26 million by 2032, with a compound annual growth rate (CAGR) of 7.4% from 2025 to 2032.
The Abdominal Aortic Aneurysm Repair Devices Market is projected to grow from USD 2803.7 million in 2025 to an estimated USD 4187.97 million by 2032, with a compound annual growth rate (CAGR) of 5.9% from 2025 to 2032.
The global Bone Densitometer Systems Market size was estimated at USD 362.51 million in 2025 and is expected to reach USD 477.04 million by 2032, growing at a CAGR of 4% from 2025 to 2032.
The global Brain PET-MRI Systems Market size was estimated at USD 410.35 million in 2025 and is expected to reach USD 604.89 million by 2032, growing at a CAGR of 5.7% from 2025 to 2032.
The global Brain Mapping Instruments Market size was estimated at USD 4587.09 million in 2025 and is expected to reach USD 8225.15 million by 2032, growing at a CAGR of 8.7% from 2025 to 2032.
The global Breast Cancer Screening Tests Market size was estimated at USD 4765.63 million in 2025 and is expected to reach USD 7572.83 million by 2032, growing at a CAGR of 6.84% from 2025 to 2032.
The global Bladder Scanners Market size was estimated at USD 495 million in 2025 and is expected to reach USD 797.47 million by 2032, growing at a CAGR of 7.05% from 2025 to 2032.
Licence Option
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$4999
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$5999
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.
Materials Scientist (privacy requested)
The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.
